236 related articles for article (PubMed ID: 20136916)
1. Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy.
Bardazzi F; Balestri R; Baldi E; Antonucci A; De Tommaso S; Patrizi A
Dermatol Ther; 2010; 23 Suppl 1():S14-9. PubMed ID: 20136916
[TBL] [Abstract][Full Text] [Related]
2. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial.
Al-Mutairi N; Nour T
Expert Opin Biol Ther; 2014 Jun; 14(6):749-56. PubMed ID: 24661040
[TBL] [Abstract][Full Text] [Related]
3. Initial experience with routine administration of etanercept in psoriasis.
de Groot M; Appelman M; Spuls PI; de Rie MA; Bos JD
Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
[TBL] [Abstract][Full Text] [Related]
4. Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project.
Naldi L; Addis A; Chimenti S; Giannetti A; Picardo M; Tomino C; Maccarone M; Chatenoud L; Bertuccio P; Caggese E; Cuscito R
Dermatology; 2008; 217(4):365-73. PubMed ID: 18810241
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
Mazzotta A; Esposito M; Costanzo A; Chimenti S
Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
[TBL] [Abstract][Full Text] [Related]
7. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
[TBL] [Abstract][Full Text] [Related]
8. Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
Smith CH; Jackson K; Bashir SJ; Perez A; Chew AL; Powell AM; Wain M; Barker JN
Br J Dermatol; 2006 Jul; 155(1):160-9. PubMed ID: 16792769
[TBL] [Abstract][Full Text] [Related]
9. Headache prevention outcome and body mass index.
Bigal ME; Gironda M; Tepper SJ; Feleppa M; Rapoport AM; Sheftell FD; Lipton RB
Cephalalgia; 2006 Apr; 26(4):445-50. PubMed ID: 16556246
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients].
Puig L
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():30-5. PubMed ID: 19080989
[TBL] [Abstract][Full Text] [Related]
11. [Clinical experience with etanercept in the treatment of psoriasis].
Martín B; Sánchez-Carazo JL; Pérez-Ferriols A; Laguna C; Oliver V; Alegre V
Actas Dermosifiliogr; 2008 Sep; 99(7):540-5. PubMed ID: 18682167
[TBL] [Abstract][Full Text] [Related]
12. Association between obesity measured by different parameters and severity of psoriasis.
Duarte GV; Oliveira Mde F; Cardoso TM; Follador I; Silva TS; Cavalheiro CM; Nonato W; Carvalho EM
Int J Dermatol; 2013 Feb; 52(2):177-81. PubMed ID: 22998685
[TBL] [Abstract][Full Text] [Related]
13. Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort.
Dalaker M; Bonesrønning JH
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):277-82. PubMed ID: 19207642
[TBL] [Abstract][Full Text] [Related]
14. Synchronous balneophototherapy is effective for the different clinical types of psoriasis.
Holló P; Gonzalez R; Kása M; Horváth A
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):578-81. PubMed ID: 16164712
[TBL] [Abstract][Full Text] [Related]
15. Impact of obesity and smoking on psoriasis presentation and management.
Herron MD; Hinckley M; Hoffman MS; Papenfuss J; Hansen CB; Callis KP; Krueger GG
Arch Dermatol; 2005 Dec; 141(12):1527-34. PubMed ID: 16365253
[TBL] [Abstract][Full Text] [Related]
16. Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults.
Gugliucci A; Kotani K; Taing J; Matsuoka Y; Sano Y; Yoshimura M; Egawa K; Horikawa C; Kitagawa Y; Kiso Y; Kimura S; Sakane N
Ann Nutr Metab; 2009; 54(3):197-201. PubMed ID: 19420913
[TBL] [Abstract][Full Text] [Related]
17. Impact of obesity on the effectiveness of adalimumab for the treatment of psoriasis: a retrospective study of 30 patients in daily practice.
Lafuente-Urrez RF; Pérez-Pelegay J
Eur J Dermatol; 2014; 24(2):217-23. PubMed ID: 24721290
[TBL] [Abstract][Full Text] [Related]
18. [Plasma levels of insulin and leptin in patients with morbid obesity and anorexia nervosa after weight loss or gain, respectively].
Escobar L; Freire JM; Girón JA; Vázquez JM; Pajares M; Ortego J; Gavilán I; Chover AJ; Carrasco M; Epinosa R; Marín F; Aguilar M
Rev Esp Med Nucl; 2000 Jun; 19(3):199-206. PubMed ID: 11062083
[TBL] [Abstract][Full Text] [Related]
19. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
[TBL] [Abstract][Full Text] [Related]
20. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
